Fátima Lasala

2.4k total citations · 1 hit paper
40 papers, 1.6k citations indexed

About

Fátima Lasala is a scholar working on Infectious Diseases, Molecular Biology and Immunology. According to data from OpenAlex, Fátima Lasala has authored 40 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Infectious Diseases, 13 papers in Molecular Biology and 13 papers in Immunology. Recurrent topics in Fátima Lasala's work include Viral Infections and Outbreaks Research (12 papers), Immunotherapy and Immune Responses (9 papers) and SARS-CoV-2 and COVID-19 Research (8 papers). Fátima Lasala is often cited by papers focused on Viral Infections and Outbreaks Research (12 papers), Immunotherapy and Immune Responses (9 papers) and SARS-CoV-2 and COVID-19 Research (8 papers). Fátima Lasala collaborates with scholars based in Spain, Israel and United States. Fátima Lasala's co-authors include Rafaël Delgado, Ángel L. Corbí, Jaime Carrillo, Javier Rojo, Joanna Luczkowiak, Laura G. Barrientos, Beatriz M. Illescas, Nazario Martı́n, Nuria Labiod and Eva Arce and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Fátima Lasala

38 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

C-Type Lectins DC-SIGN and L-SIGN Mediate Cellular Entry by Ebola Virus in cis and in trans

2002 529 citations Fátima Lasala, Ángel L. Corbí et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fátima Lasala Spain	18	787	441	399	333	240	40	1.6k
Liying Ma China	20	741 0.9×	702 1.6×	364 0.9×	266 0.8×	114 0.5×	102	1.9k
Masahiro Niikura Japan	27	691 0.9×	400 0.9×	269 0.7×	997 3.0×	149 0.6×	88	2.0k
Karen Smith Korsholm Denmark	20	629 0.8×	975 2.2×	1.5k 3.7×	512 1.5×	89 0.4×	33	2.5k
Thomas M. Kaufman United States	15	669 0.9×	282 0.6×	534 1.3×	665 2.0×	86 0.4×	26	1.3k
Ian D. Manger United States	16	458 0.6×	602 1.4×	216 0.5×	696 2.1×	171 0.7×	21	2.1k
Pierre‐Yves Lozach France	24	1.4k 1.8×	570 1.3×	508 1.3×	503 1.5×	65 0.3×	47	2.7k
Seyed Mehdi Sadat Iran	17	220 0.3×	443 1.0×	289 0.7×	292 0.9×	65 0.3×	95	1.1k
David Tyssen Australia	16	396 0.5×	479 1.1×	144 0.4×	394 1.2×	126 0.5×	28	1.4k
Mehfuz Zaman Australia	21	226 0.3×	622 1.4×	607 1.5×	147 0.4×	83 0.3×	32	1.2k
Richard S. Ginsberg United States	19	391 0.5×	921 2.1×	741 1.9×	454 1.4×	60 0.3×	25	2.2k

Countries citing papers authored by Fátima Lasala

Since Specialization

Citations

This map shows the geographic impact of Fátima Lasala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fátima Lasala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fátima Lasala more than expected).

Fields of papers citing papers by Fátima Lasala

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fátima Lasala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fátima Lasala. The network helps show where Fátima Lasala may publish in the future.

Co-authorship network of co-authors of Fátima Lasala

This figure shows the co-authorship network connecting the top 25 collaborators of Fátima Lasala. A scholar is included among the top collaborators of Fátima Lasala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fátima Lasala. Fátima Lasala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pérez‐Alonso, C., Fátima Lasala, Laura Rodríguez‐Pérez, et al.. (2025). Glycan-Silica Nanoparticles as Effective Inhibitors for Blocking Virus Infection. ACS Applied Materials & Interfaces. 17(7). 10292–10304.

Lasala, Fátima, Alfonso García‐Rubia, Beatriz Escudero-Pérez, et al.. (2024). Discovery of Thiophene Derivatives as Potent, Orally Bioavailable, and Blood–Brain Barrier-Permeable Ebola Virus Entry Inhibitors. Journal of Medicinal Chemistry. 67(18). 16381–16402. 3 indexed citations

Lasala, Fátima, et al.. (2024). HIV-1 Reverse Transcriptase Error Rates and Transcriptional Thresholds Based on Single-strand Consensus Sequencing of Target RNA Derived From In Vitro-transcription and HIV-infected Cells. Journal of Molecular Biology. 436(22). 168815–168815. 4 indexed citations

Lasala, Fátima, Nuria Labiod, Joanna Luczkowiak, et al.. (2023). MAFB shapes human monocyte–derived macrophage response to SARS-CoV-2 and controls severe COVID-19 biomarker expression. JCI Insight. 8(24). 3 indexed citations

Nieto, Concha, Fátima Lasala, Nuria Labiod, et al.. (2023). TLR7 Activation in M-CSF-Dependent Monocyte-Derived Human Macrophages Potentiates Inflammatory Responses and Prompts Neutrophil Recruitment. Journal of Innate Immunity. 15(1). 517–530. 7 indexed citations

Labiod, Nuria, et al.. (2023). The role of DC-SIGN as a trans-receptor in infection by MERS-CoV. Frontiers in Cellular and Infection Microbiology. 13. 1177270–1177270. 3 indexed citations

Cabrera‐González, Justo, Fátima Lasala, Ajay K. Monnappa, et al.. (2023). C₆₀‐based Multivalent Glycoporphyrins Inhibit SARS‐CoV‐2 Specific Interaction with the DC‐SIGN Transmembrane Receptor. Small. 20(19). e2307045–e2307045. 1 indexed citations

Luczkowiak, Joanna, Nuria Labiod, Fátima Lasala, et al.. (2022). Cross neutralization of SARS‐CoV‐2 omicron subvariants after repeated doses of COVID‐19 mRNA vaccines. Journal of Medical Virology. 95(1). e28268–e28268. 6 indexed citations

Cuesta-Geijo, Miguel Ángel, Isabel García-Dorival, Ana del Puerto, et al.. (2022). New insights into the role of endosomal proteins for African swine fever virus infection. PLoS Pathogens. 18(1). e1009784–e1009784. 34 indexed citations

10.

Thépaut, Michel, Joanna Luczkowiak, Corinne Vivès, et al.. (2021). DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist. PLoS Pathogens. 17(5). e1009576–e1009576. 134 indexed citations

11.

Folgueira, María Dolores, Joanna Luczkowiak, Fátima Lasala, Alfredo Pérez‐Rivilla, & Rafaël Delgado. (2021). Prolonged SARS-CoV-2 cell culture replication in respiratory samples from patients with severe COVID-19. Clinical Microbiology and Infection. 27(6). 886–891. 45 indexed citations

12.

Lasala, Fátima, Alfonso García‐Rubia, Inmaculada Galindo, et al.. (2021). Identification of potential inhibitors of protein-protein interaction useful to fight against Ebola and other highly pathogenic viruses. Antiviral Research. 186. 105011–105011. 15 indexed citations

13.

Negredo, Anabel, M. Habela, Eva Ramírez de Arellano, et al.. (2019). Survey of Crimean-Congo Hemorrhagic Fever Enzootic Focus, Spain, 2011–2015. Emerging infectious diseases. 25(6). 1177–1184. 50 indexed citations

14.

Mora-Rillo, Marta, Marta Arsuaga, Germán Ramírez‐Olivencia, et al.. (2015). Acute respiratory distress syndrome after convalescent plasma use: treatment of a patient with Ebola virus disease contracted in Madrid, Spain. The Lancet Respiratory Medicine. 3(7). 554–562. 88 indexed citations

15.

Lorente, Elena, Eilon Barnea, Ilan Beer, et al.. (2013). Natural HLA-B*2705 Protein Ligands with Glutamine as Anchor Motif. Journal of Biological Chemistry. 288(15). 10882–10889. 20 indexed citations

16.

Lorente, Elena, Eilon Barnea, Ilan Beer, et al.. (2013). Diversity of Natural Self-Derived Ligands Presented by Different HLA Class I Molecules in Transporter Antigen Processing-Deficient Cells. PLoS ONE. 8(3). e59118–e59118. 9 indexed citations

17.

Lorente, Elena, Eilon Barnea, Ilan Beer, et al.. (2010). Multiple, Non-conserved, Internal Viral Ligands Naturally Presented by HLA-B27 in Human Respiratory Syncytial Virus-infected Cells. Molecular & Cellular Proteomics. 9(7). 1533–1539. 22 indexed citations

18.

Lorente, Elena, Eilon Barnea, Ilan Beer, et al.. (2010). TAP-independent human histocompatibility complex-Cw1 antigen processing of an HIV envelope protein conserved peptide. AIDS. 25(2). 265–269. 5 indexed citations

19.

Caparrós, Esther, Diego Serrano‐Gómez, Amaya Puig‐Kröger, et al.. (2005). Role of the C-type lectins DC-SIGN and L-SIGN in Leishmania interaction with host phagocytes. Immunobiology. 210(2-4). 185–193. 32 indexed citations

20.

Barrientos, Laura G., Fátima Lasala, Rafaël Delgado, Anthony Sanchez, & Angela M. Gronenborn. (2004). Flipping the Switch from Monomeric to Dimeric CV-N Has Little Effect on Antiviral Activity. Structure. 12(10). 1799–1807. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact